share_log

Spero Therapeutics | DEF 14A: Definitive information statements

SEC announcement ·  Sep 1, 2023 16:08
Disclaimer: This content is for informational and educational purposes only and does not constitute a recommendation or endorsement of any specific investment or investment strategy. Read more